In contrast, Arg1+Iba1+ TAM2s were downregulated in TNBC tumor after treatment with p40 mAb, but not control IgG (Figure 8B,D), suggesting that p40 mAb immunotherapy is capable of switching TAM2 to TAM1 in TNBC tumor. This evidence concerns the gene ARG1 and neoplasm.